These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3542364)

  • 1. Modulation of the immune response by anaphylatoxins.
    Morgan EL
    Complement; 1986; 3(3):128-36. PubMed ID: 3542364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylatoxin-mediated regulation of human and murine immune responses.
    Morgan EL; Weigle WO; Hugli TE
    Fed Proc; 1984 Jul; 43(10):2543-7. PubMed ID: 6610569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the immune response by anaphylatoxin in the microenvironment of the interacting cells.
    Weigle WO; Morgan EL; Goodman MG; Chenoweth DE; Hugli TE
    Fed Proc; 1982 Dec; 41(14):3099-103. PubMed ID: 6216123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
    Meuer S; Hugli TE; Andreatta RH; Hadding U; Bitter-Suermann D
    Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of humoral immune responses by synthetic C3a peptides.
    Morgan EL; Weigle WO; Erickson BW; Fok KF; Hugli TE
    J Immunol; 1983 Nov; 131(5):2258-61. PubMed ID: 6355293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of glucose and lactate output and decrease of flow by human anaphylatoxin C3a but not C5a in perfused rat liver.
    Püschel GP; Oppermann M; Muschol W; Götze O; Jungermann K
    FEBS Lett; 1989 Jan; 243(1):83-7. PubMed ID: 2784112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of human anaphylatoxins on guinea pig atria.
    Huey R; Bloor CM; Hugli TE
    Immunopharmacology; 1984 Dec; 8(3-4):147-54. PubMed ID: 6335143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses.
    Morgan EL; Weigle WO; Hugli TE
    J Exp Med; 1982 May; 155(5):1412-26. PubMed ID: 6978374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and function of the anaphylatoxins.
    Hugli TE
    Springer Semin Immunopathol; 1984; 7(2-3):193-219. PubMed ID: 6387982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopharmacology of anaphylatoxin-induced bronchoconstrictor responses.
    Stimler-Gerard NP
    Complement; 1986; 3(3):137-51. PubMed ID: 3026723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaphylatoxins inhibit C2 production.
    Lappin D; Damerau B; Whaley K
    Clin Exp Immunol; 1983 Nov; 54(2):455-60. PubMed ID: 6317240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive complement fragments in immunoregulation.
    Morgan EL; Thoman ML; Hoeprich PD; Hugli TE
    Immunol Lett; 1985; 9(4):207-13. PubMed ID: 3873407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
    Marceau F; Hugli TE
    J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylatoxin-induced neutrophil chemotaxis and aggregation. Limited aggregation and specific desensitization induced by human C3a and synthetic C3a octapeptides.
    Nagata S; Glovsky MM; Kunkel SL
    Int Arch Allergy Appl Immunol; 1987; 82(1):4-9. PubMed ID: 3492446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac anaphylaxis. Complement activation as an amplification system.
    del Balzo U; Polley MJ; Levi R
    Circ Res; 1989 Sep; 65(3):847-57. PubMed ID: 2475275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of complement in the immune response.
    Feldbush TL; Hobbs MV; Severson CD; Ballas ZK; Weiler JM
    Fed Proc; 1984 Jul; 43(10):2548-52. PubMed ID: 6610570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease.
    Belmont HM; Hopkins P; Edelson HS; Kaplan HB; Ludewig R; Weissmann G; Abramson S
    Arthritis Rheum; 1986 Sep; 29(9):1085-9. PubMed ID: 3489467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of leukocyte regulation by complement-derived factors.
    Hugli TE; Morgan EL
    Contemp Top Immunobiol; 1984; 14():109-53. PubMed ID: 6331985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylatoxins: possible roles in disease.
    Vogt W
    Complement; 1986; 3(3):177-88. PubMed ID: 3026724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
    Sorgenfrei J; Damerau B; Vogt W
    Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.